Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P180032/S024

Cerene Cryotherapy Device

Channel Medsystems, Inc. · Decision date Sep 15, 2026

MEDTECHLEDGER EXPLANATIONP180032/S024

What did the FDA decide?

The FDA record for P180032/S024 lists the Cerene cryotherapy device, a thermal endometrial ablation device under product code MNB, with a decision of OK30 dated 2026-09-15. The supplement is a 30-Day Notice filed by Channel Medsystems, Inc. under the reason Process Change - Manufacturer/Sterilizer/Packager/Supplier. The stated change is a change in supplier of the uterine liner material. The record does not identify the prior or new supplier, the liner's material or function, or what testing supported the notice.

The S024 number ties this filing to the original PMA P180032 as a supplement, not as a new approval of the whole system. A supplier change notice is a manufacturing notification, and its reported purpose is distinct from independent proof of safety or clinical effectiveness. The record gives no clinical data, performance results, indications, or review conclusions beyond the OK30 decision code and date.

FDA approval order statement

a change in supplier of the uterine liner material
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Obstetrics/Gynecology
Decision date
Sep 15, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P180032/S024
Regulatory pathway
PMA supplement
Product code
MNB
Decision code
OK30
Decision date
Sep 15, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Device, thermal ablation, endometrial.

Product code
MNB
FDA device class
3

For the original device and its historical approval scope, see PMA P180032. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P180032 · Original PMA

    Cerene Cryotherapy Device

  2. P180032/S024 received

    Application receipt date recorded by FDA.

  3. P180032/S024 · FDA decision

    30-Day Notice

  4. P180032/S025 · Related supplement

    Cerene Cryotherapy Device (Model number FGS-7000); Exhaust Collection Bag (Model number FGS-8000); Exhaust Collection Ba

Timeline entries are records held by MedtechLedger for P180032. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P180032

Explore the linked device profile

Other records with product code MNB

Product / regulatory recordCompanyPathwayDecision dateSource
Axora Medical, Inc.PMA supplementNov 5, 2026FDA
Axora Medical, Inc.PMA approvalJul 27, 2015FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Channel Medsystems, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
5858 Horton St., Suite 200, Emeryville, CA, 94608

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records